المؤلفون: Gulikers, J L, van Veelen, A J, Driessen, J H M, Souverein, P C, Tjan-Heijnen, V C G, Hendriks, L E L, van Geel, R M J M, Croes, S

المساهمون: Afd Pharmacoepi & Clinical Pharmacology, Sub Gen. Pharmacoepi and Clinical Pharm, LS Nederlandse taalkunde, Pharmacoepidemiology and Clinical Pharmacology, PECP - Centre for Pharmacoepidemiology

مصطلحات موضوعية: CPRD Aurum, CPRD GOLD, database, primary care, Pharmacology (medical), Epidemiology

وصف الملف: application/pdf

العلاقة: https://dspace.library.uu.nl/handle/1874/432842Test

الإتاحة: https://dspace.library.uu.nl/handle/1874/432842Test

المؤلفون: Meertens, M, Muntinghe-Wagenaar, M B, Sikkema, B J, Lopez-Yurda, M, Retèl, V P, Paats, M S, Ter Heine, R, Schuuring, E, Timens, W, Touw, D J, van Boven, J F M, de Langen, A J, Hashemi, S M S, Hendriks, L E L, Croes, S, van den Heuvel, M M, Dingemans, Anne-Marie C, Mathijssen, R H J, Smit, E F, Huitema, A D R, Steeghs, N, van der Wekken, A J

المصدر: Meertens , M , Muntinghe-Wagenaar , M B , Sikkema , B J , Lopez-Yurda , M , Retèl , V P , Paats , M S , Ter Heine , R , Schuuring , E , Timens , W , Touw , D J , van Boven , J F M , de Langen , A J , Hashemi , S M S , Hendriks , L E L , Croes , S , van den Heuvel , M M , Dingemans , A-M C , Mathijssen , R H J , Smit , E F , Huitema ....

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/1269da41-d5cc-4761-8e6b-8a60aa2ecedbTest

الإتاحة: https://doi.org/10.3389/fonc.2023.1136221Test
https://hdl.handle.net/11370/1269da41-d5cc-4761-8e6b-8a60aa2ecedbTest
https://research.rug.nl/en/publications/1269da41-d5cc-4761-8e6b-8a60aa2ecedbTest
https://pure.rug.nl/ws/files/622662944/fonc_13_1136221.pdfTest

المؤلفون: Gulikers, J. L., van Veelen, A. J., Driessen, J. H. M., Souverein, P. C., Tjan‐Heijnen, V. C. G., Hendriks, L. E. L., van Geel, R. M. J. M., Croes, S.

المصدر: Pharmacoepidemiology and Drug Safety ; volume 32, issue 10, page 1161-1177 ; ISSN 1053-8569 1099-1557

الإتاحة: https://doi.org/10.1002/pds.5637Test

المؤلفون: Parikh K., Hendriks L. E. L., Bironzo P., Remon J.

المساهمون: Parikh K., Hendriks L.E.L., Bironzo P., Remon J.

مصطلحات موضوعية: Immune checkpoint inhibitor, Ipilimumab, Mesothelioma, Nivolumab, Pembrolizumab, Antineoplastic Combined Chemotherapy Protocol, Clinical Trials, Phase I as Topic, Phase II as Topic, Phase III as Topic, Human, Pleural Neoplasm, Randomized Controlled Trials as Topic, Salvage Therapy

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34174669; info:eu-repo/semantics/altIdentifier/wos/WOS:000693067900005; volume:99; firstpage:102250; lastpage:102257; numberofpages:8; journal:CANCER TREATMENT REVIEWS; http://hdl.handle.net/2318/1839581Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85108429543

الإتاحة: https://doi.org/10.1016/j.ctrv.2021.102250Test
http://hdl.handle.net/2318/1839581Test

المؤلفون: Remon J., Hendriks L. E. L., Bironzo P.

المساهمون: Remon J., Hendriks L.E.L., Bironzo P.

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34883215; info:eu-repo/semantics/altIdentifier/wos/WOS:000746376800002; volume:33; issue:2; firstpage:123; lastpage:125; numberofpages:3; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/2318/1839401Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85121217147

الإتاحة: https://doi.org/10.1016/j.annonc.2021.11.019Test
http://hdl.handle.net/2318/1839401Test

المؤلفون: Noordhof, A L, Damhuis, R A M, Hendriks, L E L, de Langen, A J, Timens, W, Venmans, B J W, van Geffen, W H

المصدر: Noordhof , A L , Damhuis , R A M , Hendriks , L E L , de Langen , A J , Timens , W , Venmans , B J W & van Geffen , W H 2021 , ' Prognostic impact of KRAS mutation status for patients with stage IV adenocarcinoma of the lung treated with first-line pembrolizumab monotherapy ' , Lung Cancer , vol. 155 , pp. 163-169 . https://doi.org/10.1016/j.lungcan.2021.04.001Test

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/d74de2bb-2b11-4f42-a7e3-aaa2ded9c096Test

الإتاحة: https://doi.org/10.1016/j.lungcan.2021.04.001Test
https://hdl.handle.net/11370/d74de2bb-2b11-4f42-a7e3-aaa2ded9c096Test
https://research.rug.nl/en/publications/d74de2bb-2b11-4f42-a7e3-aaa2ded9c096Test
https://pure.rug.nl/ws/files/168905785/Prognostic_impact_of_KRAS_mutation_status_for_patients_with_stage_IV_adenocarcinoma_of_the_lung_treated_with_first_line_pembrolizumab_monotherapy.pdfTest

المؤلفون: Cortiula F., De Ruysscher D., Steens M., Wijsman R., van der Wekken A., Alberti M., Hendriks L. E. L.

المساهمون: Cortiula, F., De Ruysscher, D., Steens, M., Wijsman, R., van der Wekken, A., Alberti, M., Hendriks, L. E. L.

مصطلحات موضوعية: Adjuvant immunotherapy, Driver genomic alteration, KRAS mutation, Progression-free survival, Stage III NSCLC, Uncommon driver genomic alteration, Unresectable NSCLC

العلاقة: volume:184; firstpage:172; lastpage:178; numberofpages:7; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11390/1244794Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85150039408

الإتاحة: https://doi.org/10.1016/j.ejca.2023.02.013Test
https://hdl.handle.net/11390/1244794Test

المؤلفون: Lefebvre, C., Martin, E., Hendriks, L. E. L., Veillon, R., Puisset, F., Mezquita, L., Ferrara, R., Sabatier, M., Filleron, T., Dingemans, A-M C., Besse, B., Raherisson, C., Mazieres, J.

المصدر: Lefebvre , C , Martin , E , Hendriks , L E L , Veillon , R , Puisset , F , Mezquita , L , Ferrara , R , Sabatier , M , Filleron , T , Dingemans , A-M C , Besse , B , Raherisson , C & Mazieres , J 2020 , ' Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapy ' , Respiratory medicine and research , vol. 78 , 100788 . https://doi.org/10.1016/j.resmer.2020.100788Test

مصطلحات موضوعية: DOCETAXEL, NIVOLUMAB, PHASE-3

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1016/j.resmer.2020.100788Test
https://cris.maastrichtuniversity.nl/en/publications/b389e444-2d7f-4412-95f5-257c11734e38Test
https://cris.maastrichtuniversity.nl/ws/files/61852283/Hendriks_2020_Immune_checkpoint_inhibitors_versus_second_line_chemotherapy.pdfTest

المؤلفون: Hendriks L. E. L., Dooms C., Berghmans T., Novello S., Levy A., De Ruysscher D., Hasan B., Giaj Levra M., Giaj Levra N., Besse B., Vansteenkiste J., Dingemans A. -M. C.

المساهمون: Hendriks L.E.L., Dooms C., Berghmans T., Novello S., Levy A., De Ruysscher D., Hasan B., Giaj Levra M., Giaj Levra N., Besse B., Vansteenkiste J., Dingemans A.-M.C.

مصطلحات موضوعية: Case-based survey, Definition, NSCLC, Oligometastatic

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31655358; info:eu-repo/semantics/altIdentifier/wos/WOS:000499645600004; volume:123; firstpage:28; lastpage:35; numberofpages:8; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/2318/1714688Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85073691396; http://www.journals.elsevier.com/european-journal-of-cancerTest/

الإتاحة: https://doi.org/10.1016/j.ejca.2019.09.013Test
http://hdl.handle.net/2318/1714688Test
http://www.journals.elsevier.com/european-journal-of-cancerTest/

المؤلفون: Dingemans, A-M C., Hendriks, L. E. L.

المصدر: Dingemans , A-M C & Hendriks , L E L 2019 , ' Immune checkpoint inhibitors in non-small-cell lung cancer : key to long-term survival? ' , The Lancet Respiratory medicine , vol. 7 , no. 4 , pp. 291-292 . https://doi.org/10.1016/S2213-2600Test(19)30043-8

مصطلحات موضوعية: PEMBROLIZUMAB

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1016/S2213-2600Test(19)30043-8
https://cris.maastrichtuniversity.nl/en/publications/d49dbe5d-12e0-465c-8976-d1db5fd20c12Test
https://cris.maastrichtuniversity.nl/ws/files/60887944/Hendriks_2019_immune_checkpoint_inhibitors_in_non.pdfTest